Chairman of the Board
Born: 1963. Board member since 2024.
Education: Diploma of marketing from Lund University, MBA from the University of Sheffield.
Other ongoing assignments: Chairman of the board in Clemondo Group AB (publ), Hammerglass AB, Här Malmö AB and board member of Gullberg & Jansson AB (publ). Previous assignments in the last five years: Board member of Roos & Tegnér AB
Holdings: 40 000 A shares through Sellwell Group.
Dependency: Independent in relation to the company and its management, independent in relation to the company's major owners.
Member of the Board
Born 1980. Board member since 2023.
Education: M. Sc. chemical engineering, Lund University of Technology, and a bachelor’s degree in business administration, Lund University School of Economics and Management.
Other ongoing assignments: CEO and board member of Life Science Partner Skåne AB, Board member of Carbiotix, and board member of Öresund Growth Partner.
Previous assignments in the last five years: None.
Holdings: 1 712 438 A shares and 111 696 via related parties.
Dependency: Independent in relation to the company and its management, independent in relation to the company's major owners.
Member of the Board
Born 1981. Board member since 2026.
Education: PhD in organic and computational chemistry, University of Oslo. European Patent Attorney, European Patent Office.
Other ongoing assignments: Chief Operating Officer at Klyv Therapeutics AS. Board member of Norwegian Board of Appeal for Industrial Property Rights.
Previous assignments in the last five years: Board member of the Norwegian Institute for Sustainability Research
Holdings: No shares in aXichem
Dependency: Independent in relation to the company and its management, independent in relation to the company's major owners.
Member of the Board
Born 1949. Board member since 2017.
Education: BSc in Biology, Bachelor of Commerce, University of Copenhagen.
Other ongoing assignments: Board deputy in Seawood AB.
Previous assignments in the last five years: Board member and COO of Bertram Pharma ApS until 2017.
Holdings: 80 225 A shares and 1 600 A shares through related parties.
Dependency: Independent in relation to the company and its management, independent in relation to the company's major owners
Member of the Board
Born 1957. Board member since 2007 and CEO since 2016.
Other ongoing assignments: CEO of aXimed AB, aXimed AS and Driftkultur AS. Chairman of Guizhou aXimed Health Food Co., Ltd, Soya AS and aXichem AS. Board member of aXimed HK Ltd, Manakin Ltd, Tofu AS and Incendia Pharma AB. Previous assignments in the last five years: None. Holdings: 16 300 A shares, 3 613 404 A shares through Manakin Ltd and 61 175 through related parties.Dependency: Dependency in relation to the company and its management, dependence in relation to the company's major owners.